Imaging Diagnosis of Hepatocellular Carcinoma The Liver Imaging Reporting and Data System, Why and How?

被引:9
作者
Cunha, Guilherme Moura [1 ]
Fowler, Kathryn J. [1 ]
Abushamat, Farid [2 ]
Sirlin, Claude B. [1 ]
Kono, Yuko [2 ]
机构
[1] Univ Calif San Diego, Dept Radiol, Liver Imaging Grp, 9500 Gilman Dr, San Diego, CA 92093 USA
[2] Univ Calif San Diego, Div Gastroenterol & Hepatol, 9500 Gilman Dr, San Diego, CA 92093 USA
关键词
Liver; Hepatocellular carcinoma; Imaging diagnosis; CHRONIC HEPATITIS-B; LI-RADS; CIRRHOSIS; ACCURACY; RISK; DISEASE; SMALLER; MRI; CT;
D O I
10.1016/j.cld.2020.07.002
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
LI-RADS provides a standardized and rigorous imaging system that aims to improve clinical practice for the care of patients with or at risk for HCC. Although CT/MRI and CEUS LI-RADS diagnose HCC in at-risk patients with comparably high specificity and PPV, clinicians should be aware of the inherent advantages and limitations of the individual modalities to maximize the utility of the algorithms. Familiarity with the similarities and differences between CT/MRI LI-RADS and CEUS LI-RADS will allow for efficient and appropriate clinical decisions based on individualized patient factors. In conclusion, the adoption of LI-RADS improves the communication among health care professionals and researchers participating in the care of patients with or at risk for HCC. Its probabilistic rather than binary approach provides clear, granular information to guide personalized management strategies. Additionally, the standardization of many aspects of HCC imaging not only results in increased accuracy of the current methods, but also facilitates the use of clinical data for further refinements and improvements, as well as the development of new clinical practices.
引用
收藏
页码:623 / 636
页数:14
相关论文
共 35 条
  • [1] Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
    Bruix, Jordi
    Reig, Maria
    Sherman, Morris
    [J]. GASTROENTEROLOGY, 2016, 150 (04) : 835 - 853
  • [2] Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents
    Calvaruso, Vincenza
    Cabibbo, Giuseppe
    Cacciola, Irene
    Petta, Salvatore
    Madonia, Salvatore
    Bellia, Alessandro
    Tine, Fabio
    Distefano, Marco
    Licata, Anna
    Giannitrapani, Lydia
    Prestileo, Tullio
    Mazzola, Giovanni
    Di Rosolini, Maria Antonietta
    Larocca, Licia
    Bertino, Gaetano
    Digiacomo, Antonio
    Benanti, Francesco
    Guarneri, Luigi
    Averna, Alfonso
    Iacobello, Carmelo
    Magro, Antonio
    Scalisi, Ignazio
    Cartabellotta, Fabio
    Savalli, Francesca
    Barbara, Marco
    Davi, Antonio
    Russello, Maurizio
    Scifo, Gaetano
    Squadrito, Giovanni
    Camma, Calogero
    Raimondo, Giovanni
    Craxi, Antonio
    Di Marco, Vito
    [J]. GASTROENTEROLOGY, 2018, 155 (02) : 411 - +
  • [3] Diagnostic value of combining 11C-choline and 18F-FDG PET/CT in hepatocellular carcinoma
    Castilla-Lievre, Maria-Angela
    Franco, Dominique
    Gervais, Philippe
    Kuhnast, Bertrand
    Agostini, Helene
    Marthey, Lysiane
    Desarnaud, Serge
    Helal, Badia-Ourkia
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (05) : 852 - 859
  • [4] Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients
    Chernyak, Victoria
    Fowler, Kathryn J.
    Kamaya, Aya
    Kielar, Ania Z.
    Elsayes, Khaled M.
    Bashir, Mustafa R.
    Kono, Yuko
    Do, Richard K.
    Mitchell, Donald G.
    Singal, Amit G.
    Tang, An
    Sirlin, Claude B.
    [J]. RADIOLOGY, 2018, 289 (03) : 816 - 830
  • [5] LI-RADS Classification and Prognosis of Primary Liver Cancers at Gadoxetic Acid-enhanced MRI
    Choi, Sang Hyun
    Lee, Seung Soo
    Park, So Hyun
    Kim, Kang Mo
    Yu, Eunsil
    Park, Yangsoon
    Shin, Yong Moon
    Lee, Moon-Gyu
    [J]. RADIOLOGY, 2019, 290 (02) : 388 - 397
  • [6] Di Costanzo GG, 2003, HEPATOLOGY, V38, P1061, DOI 10.1053/jhep.2003.50391
  • [7] European Assoc Study Liver, 2018, J HEPATOL, V69, P182, DOI 10.1016/j.jhep.2018.03.019
  • [8] Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
    Fattovich, G
    Stroffolini, T
    Zagni, I
    Donato, F
    [J]. GASTROENTEROLOGY, 2004, 127 (05) : S35 - S50
  • [9] Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors
    Fattovich, Giovanna
    Bortolotti, Flavia
    Donato, Francesco
    [J]. JOURNAL OF HEPATOLOGY, 2008, 48 (02) : 335 - 352
  • [10] LI-RADS M (LR-M): definite or probable malignancy, not specific for hepatocellular carcinoma
    Fowler, Kathryn J.
    Potretzke, Theodora A.
    Hope, Thomas A.
    Costa, Eduardo A.
    Wilson, Stephanie R.
    [J]. ABDOMINAL RADIOLOGY, 2018, 43 (01) : 149 - 157